文献速递关节外科

在全美大型医疗系统内,清创、抗生素与假体保留对比二期翻修治疗假体周围膝关节感染是否有害?

Is There Harm in Debridement, Antibiotics, and Implant Retention Versus Two-Stage Revision in the Treatment of Periprosthetic Knee Infection? Experiences Within a Large US Health Care System.
PubMed 文献 · J Arthroplasty · 2022-05-06

基于Kaiser Permanente全关节置换登记系统的队列研究纳入了2005至2018年间1410例全膝关节置换术后假体周围关节感染,其中1000例(70.9%)接受DAIR治疗。倾向评分加权Cox回归显示,DAIR组发生感染性再翻修的风险高于初始二期翻修组(HR 3.09,95%CI 2.22-4.42);DAIR失败后行二期翻修者(DAIR-F)与初始二期翻修相比,感染性再翻修风险未见差异(HR 1.11,95%CI 0.58-2.12)。

要点

  • 1410例假体周围膝关节感染中1000例(70.9%)接受DAIR治疗,150例DAIR失败(15%)后行二期翻修。
  • DAIR组感染性再翻修风险高于初始二期翻修组(HR 3.09,95%CI 2.22-4.42)。
  • DAIR失败后行二期翻修者与初始二期翻修者感染性再翻修风险未见差异(HR 1.11,95%CI 0.58-2.12)。

核心结论

  • DAIR治疗假体周围膝关节感染的感染性再翻修风险高于初始二期翻修,但DAIR失败后行二期翻修者与初始二期翻修者的感染性再翻修风险未见差异。
  • 讨论假体周围关节感染治疗方案时,功能结局、患者因素和微生物因素均值得考虑。

研究设计与样本

  • 采用Kaiser Permanente全关节置换登记系统数据开展的队列研究,纳入2005至2018年间全膝关节置换术后发生假体周围关节感染并接受DAIR或二期翻修的患者。
  • 共纳入1410例假体周围关节感染,其中1000例(70.9%)接受DAIR治疗,采用倾向评分加权Cox回归评估感染性再翻修风险。
  • 证据等级为III级。

主要发现

  • 倾向评分加权后,DAIR组感染性再翻修风险高于初始二期翻修组(HR 3.09,95%CI 2.22-4.42)。
  • DAIR手术中150例失败(15%)并后续行二期翻修(DAIR-F)。
  • 与初始二期翻修患者相比,DAIR-F后感染性再翻修风险未见差异(HR 1.11,95%CI 0.58-2.12)。

关键数值与推荐

  • DAIR对比初始二期翻修的感染性再翻修风险:HR 3.09(95%CI 2.22-4.42)。
  • DAIR-F对比初始二期翻修的感染性再翻修风险:HR 1.11(95%CI 0.58-2.12)。
  • DAIR失败率:150/1000(15%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: When faced with a periprosthetic joint infection (PJI) following total knee arthroplasty, the treating surgeon must determine whether 2-stage revision or "liner exchange," aka debridement, antibiotics, exchange of the modular polyethylene liner, and retention of fixed implants (DAIR), offers the best balance of infection eradication versus treatment morbidity. We sought to determine septic re-revision risk following DAIR compared to initial 2-stage revision. METHODS: We conducted a cohort study using data from Kaiser Permanente's total joint replacement registry. Primary total knee arthroplasty patients who went on to have a PJI treated by DAIR or 2-stage revision were included (2005-2018). Propensity score-weighted Cox regression was used to evaluate risk for septic re-revision. RESULTS: In total, 1,410 PJIs were included, 1,000 (70.9%) treated with DAIR. Applying propensity score weights, patients undergoing DAIR had a higher risk for septic re-revision compared to initial 2-stage procedures (hazard ratio 3.09, 95% CI 2.22-4.42). Of DAIR procedures, 150 failed (15%) and went on to subsequent 2-stage revision (DAIR-F). When compared to patients undergoing an initial 2-stage revision, we failed to observe a difference in septic re-revision risk following DAIR-F (hazard ratio 1.11, 95% CI 0.58-2.12). CONCLUSION: Although DAIR had a higher risk of septic re-revision, we failed to observe a difference in risk following DAIR-F when compared to those who initially underwent 2-stage revision. Functional outcome, patient, and organism factors are important to consider when discussing PJI management options. LEVEL OF EVIDENCE: Level III.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Huffaker SJ, Prentice HA, Kelly MP, et al. Is There Harm in Debridement, Antibiotics, and Implant Retention Versus Two-Stage Revision in the Treatment of Periprosthetic Knee Infection? Experiences Within a Large US Health Care System. J Arthroplasty. 2022. PMID: 35533824. doi:10.1016/j.arth.2022.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。